{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:58:11Z","timestamp":1793217491398,"version":"4.5.0"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:p>Subacute sclerosing panencephalitis (SSPE) is a relentless progressive brain disorder caused by the persistent presence of mutated measles virus in the central nervous system. The disease typically develops years after primary measles infection, with the highest risk observed in children infected before the age of 2 years. The global incidence of SSPE is notably higher in low- and middle-income countries and in regions with low measles vaccination coverage. The pathogenesis of SSPE involves viral persistence through mutations in viral proteins, enabling immune evasion and cell-to-cell propagation within the brain. Neuroinflammation, immune-mediated damage, and neuronal loss further contribute to disease progression. Clinical manifestations range from progressive cognitive decline and behavioral changes, along with myoclonus, seizures, movement disorders, visual impairment, and, finally, a vegetative state. Diagnosis is confirmed through cerebrospinal fluid analysis showing elevated antimeasles antibodies, characteristic periodic electroencephalography discharges, and neuroimaging findings like white matter hyperintensities and cerebral atrophy. Treatment remains challenging, with isoprinosine, interferon-\u03b1, ribavirin, and newer agents like favipiravir and aprepitant offering new hope. Symptomatic management and palliative care are needed in all patients. SSPE is invariably fatal. Notably, reports of prolonged survival and disease stabilization have been documented, particularly with early and combined therapy. The coronavirus disease 2019 pandemic\u2019s adverse impact on measles vaccination rates highlights the urgent need for robust measles immunization campaigns. Future directions involve exploring antiviral fusion peptide inhibitors and artificial intelligence-driven diagnostic tools to improve early detection, treatment efficacy, and outcome prediction in SSPE.<\/jats:p>","DOI":"10.4103\/aian.aian_1112_24","type":"journal-article","created":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T01:00:12Z","timestamp":1744765212000},"page":"159-168","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":19,"title":["Subacute Sclerosing Panencephalitis: Recent Advances in Pathogenesis, Diagnosis, and Treatment"],"prefix":"10.4103","volume":"28","author":[{"given":"Ravindra Kumar","family":"Garg","sequence":"first","affiliation":[{"name":"Department of Neurology, King George Medical University, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shweta","family":"Pandey","sequence":"additional","affiliation":[{"name":"Department of Neurology, King George Medical University, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,4,4]]},"reference":[{"key":"R1-20260423","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s11910-020-1023-y","article-title":"Neurological Complications of Measles (Rubeola)","volume":"20","author":"Patterson","year":"2020","journal-title":"Curr Neurol Neurosci Rep"},{"key":"R3-20260423","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.cmi.2019.10.035","article-title":"High risk of subacute sclerosing panencephalitis following measles outbreaks in Georgia","volume":"26","author":"Khetsuriani","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"R4-20260423","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejpn.2021.07.006","article-title":"A recent surge of fulminant and early onset subacute sclerosing panencephalitis (SSPE) in the United Kingdom: An emergence in a time of measles","volume":"34","author":"Lam","year":"2021","journal-title":"Eur J Paediatr Neurol"},{"key":"R5-20260423","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/INF.0000000000004234","article-title":"Patients with subacute sclerosing panencephalitis in Japan: A 2022 nationwide survey","volume":"43","author":"Okabe","year":"2024","journal-title":"Pediatr Infect Dis J"},{"key":"R6-20260423","doi-asserted-by":"crossref","first-page":"2333794X211065330","DOI":"10.1177\/2333794X211065330","article-title":"Trends and treatment of sub-acute sclerosing panencephalitis: An updated review","volume":"8","author":"Memon","year":"2021","journal-title":"Glob Pediatr Health"},{"key":"R7-20260423","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1017\/S0950268800050044","article-title":"Subacute sclerosing panencephalitis (SSPE) in Papua New Guinea: A high incidence in young children","volume":"108","author":"Lucas","year":"1992","journal-title":"Epidemiol Infect"},{"key":"R8-20260423","doi-asserted-by":"crossref","first-page":"e68909","DOI":"10.1371\/journal.pone.0068909","article-title":"Epidemiology of subacute sclerosing panencephalitis (SSPE) in Germany from 2003 to 2009: A risk estimation","volume":"8","author":"Sch\u00f6nberger","year":"2013","journal-title":"PLoS One"},{"key":"R9-20260423","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4103\/jpn.JPN_261_20","article-title":"SSPE in children younger than 3 years: A case report and systematic review of clinical manifestation and outcome","volume":"17","author":"Kumar","year":"2022","journal-title":"J Pediatr Neurosci"},{"key":"R10-20260423","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.coviro.2020.04.002","article-title":"Structural characteristics of measles virus entry","volume":"41","author":"Fukuhara","year":"2020","journal-title":"Curr Opin Virol"},{"key":"R11-20260423","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.pediatrneurol.2007.10.013","article-title":"Familial subacute sclerosing panencephalitis associated with short latency","volume":"38","author":"Sharma","year":"2008","journal-title":"Pediatr Neurol"},{"key":"R12-20260423","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s13365-016-0442-7","article-title":"Interleukin-12 (-1188) A\/C and interferon-\u03b3 (+874) A\/T gene polymorphisms in subacute sclerosing panencephalitis patients","volume":"22","author":"Dundar","year":"2016","journal-title":"J Neurovirol"},{"key":"R13-20260423","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.gene.2014.03.056","article-title":"May TLR4 Asp299Gly and IL17 His161Arg polymorphism be associated with progression of primary measles infection to subacute sclerosing panencephalitis?","volume":"547","author":"Karakas-Celik","year":"2014","journal-title":"Gene"},{"key":"R14-20260423","doi-asserted-by":"crossref","first-page":"e0034023","DOI":"10.1128\/jvi.00340-23","article-title":"Interaction of the hemagglutinin stalk region with Cell Adhesion Molecule (CADM) 1 and CADM2 mediates the spread between neurons and neuropathogenicity of measles virus with a hyperfusogenic fusion protein","volume":"97","author":"Takemoto","year":"2023","journal-title":"J Virol"},{"key":"R15-20260423","first-page":"e0175024","article-title":"The measles virus matrix F50S mutation from a lethal case of subacute sclerosing panencephalitis promotes receptor-independent neuronal spread","volume":"2024","author":"Yousaf","journal-title":"J Virol"},{"key":"R16-20260423","doi-asserted-by":"crossref","first-page":"e1011817","DOI":"10.1371\/journal.ppat.1011817","article-title":"Brain tropism acquisition: The spatial dynamics and evolution of a measles virus collective infectious unit that drove lethal subacute sclerosing panencephalitis","volume":"19","author":"Yousaf","year":"2023","journal-title":"PLoS Pathog"},{"key":"R17-20260423","doi-asserted-by":"crossref","first-page":"eadf3731","DOI":"10.1126\/sciadv.adf3731","article-title":"Collective fusion activity determines neurotropism of an en bloc transmitted enveloped virus","volume":"9","author":"Shirogane","year":"2023","journal-title":"Sci Adv"},{"key":"R18-20260423","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1177\/0883073819860631","article-title":"Role of the Th1 and Th17 pathway in subacute sclerosing panencephalitis","volume":"34","author":"Uygun","year":"2019","journal-title":"J Child Neurol"},{"key":"R19-20260423","doi-asserted-by":"crossref","first-page":"258","DOI":"10.5414\/NP300843","article-title":"A 29-year-old pregnant woman with worsening left hemiparesis, encephalopathy, and hemodynamic instability: A case report of subacute sclerosing panencephalitis","volume":"34","author":"Reis","year":"2015","journal-title":"Clin Neuropathol"},{"key":"R20-20260423","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/jnen\/nlae017","article-title":"TDP-43 pathology in subacute sclerosing panencephalitis","volume":"83","author":"Acewicz","year":"2024","journal-title":"J Neuropathol Exp Neurol"},{"key":"R21-20260423","doi-asserted-by":"crossref","first-page":"e13069","DOI":"10.1111\/bpa.13069","article-title":"Independent distribution between tauopathy secondary to subacute sclerotic panencephalitis and measles virus: An immunohistochemical analysis in autopsy cases including cases treated with aggressive antiviral therapies","volume":"32","author":"Miyahara","year":"2022","journal-title":"Brain Pathol"},{"key":"R22-20260423","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/mds.28323","article-title":"The spectrum of repetitive behaviors associated with subacute sclerosing panencephalitis","volume":"36","author":"Pandey","year":"2021","journal-title":"Mov Disord"},{"key":"R23-20260423","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1001\/archneur.1979.00500460044004","article-title":"The variable natural history of subacute sclerosing panencephalitis: A study of 118 cases from the Middle East","volume":"36","author":"Risk","year":"1979","journal-title":"Arch Neurol"},{"key":"R24-20260423","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/mdc3.14062","article-title":"Movement disorders in patients with subacute sclerosing panencephalitis: A systematic review","volume":"11","author":"Garg","year":"2024","journal-title":"Mov Disord Clin Pract"},{"key":"R25-20260423","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.4269\/ajtmh.23-0004","article-title":"Vision loss in subacute sclerosing panencephalitis: A systematic review of case reports and case series","volume":"108","author":"Garg","year":"2023","journal-title":"Am J Trop Med Hyg"},{"key":"R26-20260423","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1017\/S1092852924000038","article-title":"The spectrum of psychiatric manifestations in subacute sclerosing panencephalitis: A systematic review of published case reports and case series","volume":"29","author":"Garg","year":"2024","journal-title":"CNS Spectr"},{"key":"R27-20260423","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.3855\/jidc.15200","article-title":"Oligoclonal bands: A laboratory diagnosis of subacute sclerosing panencephalitis (SSPE)","volume":"16","author":"Rinawati","year":"2022","journal-title":"J Infect Dev Ctries"},{"key":"R28-20260423","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/1348-0421.13017","article-title":"Diagnostic reference value of antibody levels measured using enzyme immunoassay for subacute sclerosing panencephalitis","volume":"66","author":"Kume","year":"2022","journal-title":"Microbiol Immunol"},{"key":"R29-20260423","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1177\/15500594221137050","article-title":"The EEG features of four cases of subacute sclerosing panencephalitis in North China: SSPE EEG features","volume":"55","author":"Wang","year":"2024","journal-title":"Clin EEG Neurosci"},{"key":"R30-20260423","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00062-024-01396-1","article-title":"Neuroimaging abnormalities in patients with subacute sclerosing panencephalitis: Prospective follow-up study","volume":"34","author":"Keerthiraj","year":"2024","journal-title":"Clin Neuroradiol"},{"key":"R31-20260423","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/08830738241272074","article-title":"Association between clinical severity, neuroimaging, and electroencephalographic findings in children with subacute sclerosing panencephalitis","volume":"39","author":"Panda","year":"2024","journal-title":"J Child Neurol"},{"key":"R32-20260423","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1002\/ana.26520","article-title":"Cavitating leukoencephalopathy in subacute sclerosing panencephalitis","volume":"92","author":"Kathait","year":"2022","journal-title":"Ann Neurol"},{"key":"R33-20260423","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s40475-023-00291-y","article-title":"Seizures as presenting feature of subacute sclerosing panencephalitis: A systematic review of case reports and case series","volume":"10","author":"Garg","year":"2023","journal-title":"Curr Trop Med Rep"},{"key":"R34-20260423","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-0040-1715623","article-title":"Atypical presentation of fulminating subacute sclerosing panencephalitis: A case series","volume":"52","author":"Dey","year":"2021","journal-title":"Neuropediatrics"},{"key":"R35-20260423","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1007\/s10072-023-06650-x","article-title":"Obstetric outcomes in pregnant women with subacute sclerosing panencephalitis (SSPE): A systematic review of case reports and case series","volume":"44","author":"Garg","year":"2023","journal-title":"Neurol Sci"},{"key":"R36-20260423","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/aian.aian_655_22","article-title":"Disease-modifying therapy in subacute sclerosing panencephalitis: An area of darkness","volume":"26","author":"Garg","year":"2023","journal-title":"Ann Indian Acad Neurol"},{"key":"R37-20260423","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11940-022-00710-x","article-title":"Options in the treatment of subacute sclerosing panencephalitis: Implications for low resource areas","volume":"24","author":"Samia","year":"2022","journal-title":"Curr Treat Options Neurol"},{"key":"R38-20260423","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1007\/s12325-019-00995-6","article-title":"Inosine pranobex: A key player in the game against a wide range of viral infections and non-infectious diseases","volume":"36","author":"Sliva","year":"2019","journal-title":"Adv Ther"},{"key":"R39-20260423","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/eji.201847948","article-title":"Inosine pranobex enhances human NK cell cytotoxicity by inducing metabolic activation and NKG2D ligand expression","volume":"50","author":"McCarthy","year":"2020","journal-title":"Eur J Immunol"},{"key":"R40-20260423","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/INF.0b013e31812e01e8","article-title":"Continuous intrathecal interferon alpha application in subacute sclerosing panencephalitis","volume":"26","author":"Thurner","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"R41-20260423","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.braindev.2004.07.003","article-title":"Long-term follow-up of a patient with subacute sclerosing panencephalitis successfully treated with intrathecal interferon alpha","volume":"27","author":"Miyazaki","year":"2005","journal-title":"Brain Dev"},{"key":"R42-20260423","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1177\/088307380301801201","article-title":"Randomized treatment study of inosiplex versus combined inosiplex and intraventricular interferon-alpha in subacute sclerosing panencephalitis (SSPE): International multicenter study","volume":"18","author":"Gascon","year":"2003","journal-title":"J Child Neurol"},{"key":"R43-20260423","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00702-021-02306-2","article-title":"Amantadine: Reappraisal of the timeless diamond-target updates and novel therapeutic potentials","volume":"128","author":"Danysz","year":"2021","journal-title":"J Neural Transm (Vienna)"},{"key":"R44-20260423","doi-asserted-by":"crossref","DOI":"10.1136\/practneurol-2020-002880","article-title":"Adult-onset subacute sclerosing panencephalitis","author":"Nair","year":"2021","journal-title":"Pract Neurol"},{"issue":"9","key":"R45-20260423","doi-asserted-by":"crossref","DOI":"10.47895\/amp.v56i9.5341","article-title":"Short-term outcomes of the use of intraventricular ribavirin in filipino patients with subacute sclerosing panencephalitis","volume":"56","author":"Lukban","year":"2022","journal-title":"Acta Med Philipp"},{"key":"R46-20260423","doi-asserted-by":"crossref","first-page":"e0187423","DOI":"10.1128\/jvi.01874-23","article-title":"Functional properties of measles virus proteins derived from a subacute sclerosing panencephalitis patient who received repeated remdesivir treatments","volume":"98","author":"Schmitz","year":"2024","journal-title":"J Virol"},{"key":"R47-20260423","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.pediatrneurol.2020.05.009","article-title":"Aprepitant in the treatment of subacute sclerosing panencephalitis: A randomized, double-blind, placebo-controlled study","volume":"110","author":"Oncel","year":"2020","journal-title":"Pediatr Neurol"},{"key":"R48-20260423","doi-asserted-by":"crossref","first-page":"1203144","DOI":"10.3389\/fnut.2023.1203144","article-title":"Low glycemic index therapy in children with sub-acute sclerosing panencephalitis (SSPE): An experience from a measles-endemic country","volume":"10","author":"Ibrahim","year":"2023","journal-title":"Front Nutr"},{"key":"R49-20260423","doi-asserted-by":"crossref","first-page":"57","DOI":"10.5334\/tohm.972","article-title":"Substantial improvement in a patient with subacute sclerosing panencephalitis: An unusual case report","volume":"14","author":"Jain","year":"2024","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"key":"R50-20260423","doi-asserted-by":"crossref","first-page":"577656","DOI":"10.1016\/j.jneuroim.2021.577656","article-title":"Favorable outcomes of interferon-\u03b1 and ribavirin treatment for a male with subacute sclerosing panencephalitis","volume":"358","author":"Sonoda","year":"2021","journal-title":"J Neuroimmunol"}],"container-title":["Annals of Indian Academy of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/aian.aian_1112_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:00:57Z","timestamp":1786647657000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/aian.aian_1112_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/aian.aian_1112_24","relation":{},"ISSN":["0972-2327","1998-3549"],"issn-type":[{"value":"0972-2327","type":"print"},{"value":"1998-3549","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"2024-12-26","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-21","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}